Nature's Sunshine Products (NASDAQ: NATR) reported Q4 EPS of $0.05, versus $0.06 reported last year. Revenue for the quarter came in at $91.7 million, versus $97.4 million reported last year.

Fourth Quarter 2019 Highlights

• Net sales decreased 5.8 percent to $91.7 million from $97.4 million in 2018
• GAAP net income was $1.2 million compared to a net loss of $2.8 million in the prior year
• GAAP net income per diluted share was $0.05 compared to a net loss of $0.15 per share in the prior year
• Adjusted net income per diluted share increased to $0.05 compared to adjusted net loss of $0.06 per share in the prior year
• Adjusted EBITDA increased 89.2 percent to $7.6 million from $4.0 million in the prior year

Management Commentary

“I’m extremely pleased with the progress we made in 2019 on our global transformation. We spent the last half of the year focused on our Global Growth Strategy, creating a series of groundbreaking initiatives to strengthen our brand, improve field fundamentals, expand digital capabilities, extend our manufacturing leadership, and enhance our organization capabilities. We also focused on improving profitability by implementing a comprehensive restructuring program and reducing unprofitable sales initiatives. As a result, operating profit almost tripled while adjusted EBITDA increased 77.6 percent versus prior year,” said Terrence Moorehead, Chief Executive Officer. “In 2020, our plan is to accelerate our global strategies while remaining focused on driving costs out of the business to deliver further profit improvements. In the coming months, we anticipate delivering a new and significantly improved distributor and customer experience. This includes the launch of exciting new branding, a new consumer-centric website and ecommerce platform, new digital tools and the launch of additional products within our line of hemp-derived CBD products.”

“Like everyone else operating in Asia, we also need to navigate the near-term challenges posed by the coronavirus. Several of our largest markets have been negatively affected by the outbreak. Having said that, our first priority, is the health and safety of our employees, distributors and customers and we are taking all of the necessary precautions. While it’s still too early to fully understand the financial impact on the business, we anticipate Q1 revenue to be significantly down in Asia and will monitor the situation as it develops. Local management teams are adjusting workflows and processes in an effort to adapt to the situation on the ground,” continued Moorehead.

For earnings history and earnings-related data on Nature's Sunshine Products (NATR) click here.